U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 21 to 40 of 102

Tests names and labsConditionsGenes, analytes, and microbesMethods

Comprehensive PGx Panel

Dynamic DNA Laboratories, LLC
United States
12518
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Gravity Pharmacogenetics Comprehensive Profile

Gravity Diagnostics
United States
8617
  • T Targeted variant analysis

Genetic study of pharmacogenetics

HeartGenetics, Genetics and Biotechnology, SA
Portugal
126
  • T Targeted variant analysis

Tempus nP

Tempus Labs, Inc.
United States
413
  • T Targeted variant analysis

Rxight Pharmacogenetics Program

MD Labs
United States
628
  • T Targeted variant analysis

Genetic Study of Clopidogrel Pharmacogenetics

HeartGenetics, Genetics and Biotechnology, SA
Portugal
11
  • T Targeted variant analysis

CARDIOpgx

Eugenomic S.L.
Spain
116
  • T Targeted variant analysis

PSICOpgx

Eugenomic S.L.
Spain
19
  • T Targeted variant analysis

GLOBALpgx

Eugenomic S.L.
Spain
121
  • T Targeted variant analysis

CYP2C19 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CYP2C19 single gene analysis

SPMED CO., LTD Step forward Personalized Medicine
South Korea
181
  • C Sequence analysis of the entire coding region

PGx-NP (Neuro-Psychiatry)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
5126
  • T Targeted variant analysis

PGx-Premium (Preemptive PGx test)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
6627
  • T Targeted variant analysis

PGx-Standard (Preemptive PGx test)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
3110
  • T Targeted variant analysis

iDNA PGx-CNS

iDNA Genomics
Greece
3012
  • T Targeted variant analysis

Pharmacogenomics SNaP-Shot

Ariel Precision Medicine
United States
126
  • T Targeted variant analysis

Polypharmacy Comprehensive Panel

Invitae
United States
3324
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Clopidogrel, impaired responsiveness to, 609535, Autosomal recessive (Resistance to clopidogrel) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Clopidogrel, impaired responsiveness to, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Mephenytoin poor metabolizer, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Results: 21 to 40 of 102

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.